APG-115 in Combination With PD-1 Inhibitor in Patients With Advanced Liposarcoma or Advanced Solid Tumors

NCT04785196 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

95

Enrollment

INDUSTRY

Sponsor class

Conditions

Liposarcoma
Advanced Solid Tumor

Interventions

DRUG: APG-115
DRUG: Toripalimab

Sponsor

Ascentage Pharma Group Inc.

Collaborators

[object Object]